The New Jersey Medical School Global Tuberculosis Institute at Rutgers, The State University of New Jersey is a force in the effort to conquer and cure tuberculosis worldwide. The Institute plays a leading role in the international arena, providing expertise in program development, education and training and research to ministers of health, national TB programs and healthcare providers around the globe.
The Institute's work has no borders. Battling TB on the front lines, it has a proven track record in building the political will and international cooperation needed to relegate this disease to the history books, where it belongs.
Eleven Nurses win the 3rd ICN/Lilly Award for Work in Tuberculosis and Multi-drug Resistant TB
On the occasion of World TB Day, the International Council of Nurses (ICN), in partnership with Eli Lilly and Company, conferred special awards to the following nurses who have demonstrated exceptional dedication to the fight against the scourge of tuberculosis (TB) in their countries.
When RESULTS and REF began advocating for tuberculosis (TB) funding in 1997 as a key poverty and health issue, the U.S. was providing less than $1 million in global TB funding. Since then, we've helped members of Congress realize that not only is TB a global epidemic, but the fight against HIV/AIDS will not succeed without an equally aggressive effort against TB. In 2008, the historic Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 was signed into law, authorizing $48 billion over five years for life-saving programs, including $4 billion for TB and a goal of treating 4.5 million people.
To reach this authorized level, Congress must begin to scale up TB funding as envisioned in this historic legislation. RESULTS continues to lead advocacy efforts to urge Congress to increase funding for the Global Fund in our annual appropriations (foreign aid spending) bill.
Eleven Nurses Win the 2nd ICN/Lilly Award for Work in Tuberculosis and Multi–drug Resistant TB
On the occasion of World TB Day, the International Council of Nurses (ICN), in partnership with Eli Lilly and Company, conferred special awards to nurses working on the ground in fighting the scourge of tuberculosis (TB) and multi-drug resistant TB. The 2008 award recipients come from six TB affected countries: Kenya, Lesotho, Malawi, the Russian Federation, South Africa and Swaziland.
The Stop TB Partnership is leading the way to a world without tuberculosis (TB), a disease that is curable but still kills three people every minute. Founded in 2001, the Partnership's mission is to serve every person who is vulnerable to TB and ensure that high-quality treatment is available to all who need it.
Together our nearly 1000 partners are a collective force that is transforming the fight against TB in more than 100 countries. They include international and technical organizations, government programmes, research and funding agencies, foundations, NGOs, civil society and community groups and the private sector.
We operate through a secretariat hosted by the World Health Organization (WHO) in Geneva, Switzerland and seven working groups whose role is to accelerate progress on access to TB diagnosis and treatment; research and development for new TB diagnostics, drugs and vaccines; and tackling drug resistant- and HIV-associated TB. The secretariat is governed by a coordinating board that sets strategic direction for the global fight against TB.
Five Nurses Win the Newly Launched ICN/Lilly Award for Work in Tuberculosis and Multi–drug Resistant TB.
TB Alert believes in a world without TB. It is possible. TB is curable, and early diagnosis and treatment helps to prevent the spread of TB. Unfortunately, it is not that simple. Whilst it is clinically possible to diagnose and treat most forms of the disease effectively, the people most vulnerable to TB – who tend to be the poorest and most marginalised in society – all too frequently fall through the gaps in service provision. As many as 40% of the 8.8 million people who develop the disease each year never reach a qualified doctor – those that do, frequently delay going to a doctor until the illness is advanced and therefore more difficult to treat. Even when people do receive a timely and accurate diagnosis, and are started on medication for TB, too many cease treatment before they have been successfully cured of the disease.
Working within national TB control programmes, TB Alert promotes a collaborative, social model of health to address TB. This model considers the social, cultural and economic factors that make some people more vulnerable to TB; less likely to seek help for possible TB symptoms; and less able to complete treatment successfully if diagnosed with the illness.
The mission of the Centres for Disease Control and Prevention Division of Tuberculosis Elimination (DTBE) is to promote health and quality of life by preventing, controlling, and eventually eliminating tuberculosis from the United States, and by collaborating with other countries and international partners in controlling global tuberculosis.
Health is one of the World Economic Forum's key focus areas as it is directly aligned with the Forum's mission: Committed to improving the state of the world by engaging leaders in shaping the global, regional and industry agendas. The Forum focuses on three key health-related activities: advocacy, dialogue and action through partnership.
The Forum recognises health as an important part of long-term economic development and engages its members and other stakeholders to advocate health as an investment.
The WHO Global TB Programme aims to advance universal access to TB prevention, care and control, guide the global response to threats, and promote innovation.